Umang Vohra is the Managing Director and Global Chief Executive Officer (CEO) of Cipla Limited, an Indian multinational pharmaceutical company headquartered in Mumbai. He has been leading the company since September 2016.
The company has a market capitalisation of Rs 1,00,000 crore as of September 8, 2023. The share price of the company was Rs 1,243 on Friday. As Cipla’s MD and GCEO, Vohra’s priorities have been Cipla’s strategic growth, defining and executing Cipla’s roadmap to maintain momentum in home markets.
He joined Cipla Limited in 2015. He holds a bachelor's degree in Engineering - BE, Computer Science from MSRIT, Bangalore. He also holds an MBA from TA PAI Management Institute. Before joining Cipla, Vohra worked with Eicher Motors, PepsiCo and Dr Reddy’s Laboratories.
He joined Cipla in 2015 as Chief Operating Officer. He has almost two decades of experience with a deep understanding and experience of various aspects of the global pharmaceutical business. Vohra is a firm believer in the power of agile business models, disruptive technologies, data-driven analytics and a future-ready workforce with a view to making a difference in the lives of patients.
Cipla primarily develops medicines to treat respiratory disease, arthritis, diabetes, depression, and many other medical conditions. The pharma company has 47 manufacturing locations across the world and sells its products in 86 countries.
Cipla was founded by Khwaja Abdul Hamied as a Chemical, Industrial and Pharmaceutical Laboratories in Mumbai. In July 1984, the name of the company was changed to 'Cipla Limited'.
READ | Meet man who works for Rs 2,71,000 crore company, son of India's second richest pharma billionaire
